Table 1.

Study population baseline characteristics.

	HCC (n = 108)	MLT (n = 138)	P
Age (year), median(range)	55.72 (28–82)	56.72 (32–84)	0.934
Sex
Male	97 (89.8%)	74 (53.6%)	˂0.001*
Female	11 (10.2%)	64 (46.4%)
Liver disease
Cirrhosis	53 (49.1%)	1 (0.7%)	˂0.001*
Chronic hepatitis B	94 (87.0%)	20(14.5%)	˂0.001*
Size of hepatic tumors (cm), median (range)	6.28 (1.5–20.6)	4.27(0.8–15.2)	0.003*
Shape of hepatic tumors
Round	64 (59.3%)	100 (72.5%)	0.029*
Lobulated or irregular	44 (40.7%)	38 (27.5%)
Margin of hepatic tumors
Clear	71 (65.7%)	98 (71.0%)	0.376
Ill-defined	37 (34.2%)	40 (29.0%)
BUS echo
Hypo-echo	79 (73.1%)	108 (78.3%)	0.665
Iso-echo	6 (5.5%)	7 (5.1%)
Hyper-echo	20 (18.5%)	18 (13.0%)
Mixed-echo	3 (2.8%)	5 (3.6%)
Method of sampling
Biospy	35 (32.4%)	51 (37.0%)	0.458
Sugery	73 (67.6%)	87 (63.0%)
BMI, median (range)	22.1 (16.2–28.3)	21.5 (17.3–28.6)	0.384
Distance between skin and tumor (cm), median (range)	6.5 (1.2–14.5)	7.2 (1.1–13.8)	0.857

Data in parentheses are shown as percentages.

*Statistically significant.